WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...

The Genesee County Health Department is offering no-cost testing during National HIV Testing Day at the Genesee Free Medical ...

Yeztugo, generic name lenacapavir (LEN), has been approved after nearly eliminating the spread of HIV among trial patients.

In clinical trials, researchers found Yeztugo to be highly effective as a twice-yearly form of pre-exposure prophylaxis.

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

Researchers at MIT and the Scripps Research Institute have shown that they can generate a strong immune response to HIV with ...

A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One ...

The US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV -- a move ...

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...